Why providers are denouncing CMS’ new payment rules

The latest stories trending on MedCity News.

Editor's Pick

Top Story Why Provider Groups Are Denouncing CMS' New Payment Rules CMS finalized updates to its physician fee schedule for 2024, as well as finalized the rule for next year's Outpatient Prospective Payment System (OPPS). Provider groups are displeased with the updated rules, arguing that both physicians and provider organizations need more monetary relief than what the agency is offering. Sponsored Content Navigating Healthcare's Data Revolution: Priorities, Opportunities, and Challenges for Health Systems Presented by Arcadia Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here's what we found. Do You Want To Improve Your Patient Flow? Presented by Care Logistics Learn how you can improve your patient flow and drive operational efficiency. Plus, gain an increase in revenue per case and hard dollar benefit along with a decrease in length of stay.  Join us Nov 9th as experts discuss how hospitals can improve these and so much more during this live webinar. Reserve My Seat

Featured News

The Case for Hiring an Investment Bank: Adding Value to Your Value Proposition The "right" investment banker for you with the appropriate experience can not only tell you what your company is worth, they can also utilize their expertise to establish and run an appropriate, bespoke transaction process that will serve to reduce risk and maximally benefit you and your company's future potential, valuation or even sale price – and they should be equally willing and able to A Paradigm Shift Towards Reimbursing the Root Causes of Diseases Medicare needs to incentivize providers by reimbursing them for identifying and addressing social determinants of health. Doing so will ultimately improve patient health outcomes and simultaneously save risk-bearing organizations money. Biotech Startup Triveni Unveils $92M to Address Barrier to Treating Inflammation Available atopic dermatitis drugs work by blocking inflammation, but Triveni Bio is developing an antibody that addresses a root cause of the chronic condition. The startup is out of stealth to advance its lead program and a pipeline of other inflammation and immunology drugs. West Monroe: 64% of Health Insurer Execs Say Digital Transformation is a Top Priority Despite most insurer execs saying that digital transformation is a top priority, only 8% believe the majority of their staff embrace digital transformation, according to data from West Monroe.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Jeff Smith, CEO of Bamboo Health For October's guest interview, we are joined by Jeff Smith, who became the CEO of digital health company Bamboo Health this month. Before Bamboo, Smith held several leadership positions at Lumeris, a value-based care managed services operator for health systems. Before that, he spent more than six years in leadership roles at CVS. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe